AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32396017 — intervention group
Group type: EXPERIMENTAL
Intervention: New Zealand blackcurrant (NZBC) extract (two capsules of 300 mg each, 7-day intake)
Number of subjects: 14
Study 32396017 — intervention group
Group type: EXPERIMENTAL
Intervention: New Zealand blackcurrant (NZBC) extract (7-day intake)
Number of subjects: 14
Study 32396017 — intervention group
Group type: COMPARATOR
Intervention: Placebo (7-day intake)
Number of subjects: 14
Study 36149885 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2.5 mg letrozole and 50 mg clomiphene (CC)
Number of subjects: 80
Study 32191159 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare need levels derived from WHO Disability Assessment Schedule 2.0
Number of subjects: 504
Study 32191159 — intervention group
Group type: COMPARATOR
Intervention: Middle healthcare need cluster
Number of subjects: 504
Study 32191159 — intervention group
Group type: COMPARATOR
Intervention: Higher healthcare need cluster
Number of subjects: 504
Study 36075200 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemadsorption therapy (HT) using a CytoSorb® adsorber for up to 5 days, replaced every 18-24 hours.
Number of subjects: 24
Study 36075200 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT).
Number of subjects: 24
Study 36075200 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemadsorption therapy (HT)
Number of subjects: 24
Study 36075200 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 24
Study 34265491 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (2000 IU/d)
Number of subjects: 44
Study 34265491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 35056360 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings (20-25 mm Hg compression)
Number of subjects: 16
Study 35056360 — intervention group
Group type: COMPARATOR
Intervention: No compression stockings (control)
Number of subjects: 16
Study 32147046 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulberry leaves (12 mg of mulberry DNJ three times daily)
Number of subjects: 0
Study 32147046 — intervention group
Group type: COMPARATOR
Intervention: Control group (0 mg of DNJ)
Number of subjects: 0
Study 35797235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) AZD7442, 600 mg
Number of subjects: 110
Study 35797235 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (i.v.) AZD7442, 300 mg
Number of subjects: 110
Study 34449181 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 7437
Study 34449181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7437
Study 35976758 — intervention group
Group type: COMPARATOR
Intervention: Alzheimer's disease label
Number of subjects: 151
Study 35976758 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe stage of Alzheimer's disease
Number of subjects: 151
Study 35976758 — intervention group
Group type: COMPARATOR
Intervention: Mild stage of Alzheimer's disease
Number of subjects: 151
Study 34984028 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D 5000 IU once daily plus standard treatment (pregabalin, gabapentin, or amitriptyline) for 8 weeks
Number of subjects: 68
Study 34984028 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 68
Study 33289129 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐dots at a concentration of 530 g L‐1
Number of subjects: 0
Study 33289129 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐dots in BNC
Number of subjects: 0
Study 33289129 — intervention group
Group type: EXPERIMENTAL
Intervention: BNC sheet with C‐dots
Number of subjects: 0
Study 33136074 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk stability exercise with abdominal hollowing or bracing maneuvers
Number of subjects: 30
Study 33136074 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapeutic exercise program
Number of subjects: 30
Study 616515918 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure disease management
Number of subjects: 0
Study 616515918 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32645890 — intervention group
Group type: EXPERIMENTAL
Intervention: Paddling at 45 strokes-min-1 (spm)
Number of subjects: 10
Study 32645890 — intervention group
Group type: COMPARATOR
Intervention: Paddling at 65 strokes-min-1 (spm)
Number of subjects: 10
Study 32645890 — intervention group
Group type: COMPARATOR
Intervention: Paddling at 55 strokes-min-1 (spm)
Number of subjects: 10
Study 33687643 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 65
Study 34188733 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic artery embolization (PAE)
Number of subjects: 6
Study 32702522 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediated conflict discussion
Number of subjects: 36
Study 32702522 — intervention group
Group type: COMPARATOR
Intervention: Non-mediated conflict discussion
Number of subjects: 36
Study 32702522 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediated condition
Number of subjects: 36
Study 32702522 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who felt more satisfied after conflict resolution
Number of subjects: 36
Study 35126684 — intervention group
Group type: EXPERIMENTAL
Intervention: SHR4640 10 mg plus febuxostat 80 mg
Number of subjects: 93
Study 35126684 — intervention group
Group type: EXPERIMENTAL
Intervention: SHR4640 10 mg plus febuxostat 40 mg
Number of subjects: 93
Study 35126684 — intervention group
Group type: EXPERIMENTAL
Intervention: SHR4640 5 mg plus febuxostat 20 mg
Number of subjects: 93
Study 35126684 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 93
Study 33026515 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred music
Number of subjects: 97
Study 33026515 — intervention group
Group type: COMPARATOR
Intervention: Operating room noise
Number of subjects: 97
Study 36228569 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus rhamnosus GG (LGG)
Number of subjects: 169
Study 36228569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study 32719011 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-menthol cigarettes
Number of subjects: 122
Study 32719011 — intervention group
Group type: COMPARATOR
Intervention: Menthol cigarettes
Number of subjects: 122
Study 34973303 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intra-incisional bupivacaine
Number of subjects: 31
Study 34973303 — intervention group
Group type: COMPARATOR
Intervention: Control (no bupivacaine)
Number of subjects: 31
Study 33444359 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (150 minutes per week for 52 weeks)
Number of subjects: 117
Study 33444359 — intervention group
Group type: COMPARATOR
Intervention: Education control intervention
Number of subjects: 117
Study 33744933 — intervention group
Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 2964
Study 33744933 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa or darbepoetin alfa
Number of subjects: 2964
Study 34554694 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Radiofrequency (PRF) treatment of the saphenous nerve
Number of subjects: 70
Study 34554694 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (sham procedure with motor stimulation)
Number of subjects: 70
Study 33801688 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil emulsion enriched with omega-3 fatty acids
Number of subjects: 58
Study 33801688 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil emulsion containing omega-6 fatty acids
Number of subjects: 58
Study 32121066 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of Undaria pinnatifida fucoidan (UPF)
Number of subjects: 0
Study 32121066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34448986 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (Headspace)
Number of subjects: 116
Study 34448986 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 116
Study 34138672 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ Shoulder Injury Prevention Program (FIFA 11+S) performed before all training sessions for 1 season (6 months)
Number of subjects: 726
Study 34138672 — intervention group
Group type: COMPARATOR
Intervention: Usual routine warm‐up program before training sessions for 1 season
Number of subjects: 726
Study 34138672 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+S program
Number of subjects: 726
Study 32323904 — intervention group
Group type: EXPERIMENTAL
Intervention: FMR with lyophilized growth factors
Number of subjects: 25
Study 32323904 — intervention group
Group type: COMPARATOR
Intervention: FMR with saline (placebo)
Number of subjects: 25
Study 35720066 — intervention group
Group type: EXPERIMENTAL
Intervention: Safinamide (50 mg/day for 2 weeks and 100 mg/day for 22 weeks)
Number of subjects: 30
Study 35720066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35720066 — intervention group
Group type: EXPERIMENTAL
Intervention: Safinamide (post-hoc analysis)
Number of subjects: 30
Study 36367004 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 10 mg and sufentanil (NS1)
Number of subjects: 160
Study 36367004 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 10 mg and sufentanil 20 mg (NS2)
Number of subjects: 160
Study 36367004 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 30 mg and sufentanil 20 mg (NS3)
Number of subjects: 160
Study 36367004 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil (S)
Number of subjects: 160
Study 32030525 — intervention group
Group type: EXPERIMENTAL
Intervention: Game Changers intervention
Number of subjects: 99
Study 35912157 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX+general anesthesia
Number of subjects: 90
Study 33471169 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal sodium citrate
Number of subjects: 60
Study 33471169 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated left nasal cavity)
Number of subjects: 60
Study 32487465 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (N = 18)
Number of subjects: 51
Study 32487465 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga (N = 21)
Number of subjects: 51
Study 32487465 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (N = 12)
Number of subjects: 51
Study 35634851 — intervention group
Group type: EXPERIMENTAL
Intervention: Viltolarsen
Number of subjects: 16
Study 35634851 — intervention group
Group type: COMPARATOR
Intervention: Control (matched historical control group)
Number of subjects: 16
Study 35078536 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE) intervention
Number of subjects: 64
Study 35078536 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 64
Study 32694705 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pharmaceutical dry eye therapy
Number of subjects: 0
Study 32694705 — intervention group
Group type: COMPARATOR
Intervention: Daily saline eye wash
Number of subjects: 0
Study 36076295 — intervention group
Group type: EXPERIMENTAL
Intervention: Communities That Heal (CTH) intervention
Number of subjects: 0
Study 36076295 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study 33930408 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprotumumab (8 infusions every 3 weeks)
Number of subjects: 170
Study 35795940 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk walking group (Group C)
Number of subjects: 131
Study 35795940 — intervention group
Group type: COMPARATOR
Intervention: Static control group (Group A)
Number of subjects: 131
Study 35795940 — intervention group
Group type: COMPARATOR
Intervention: Walking group (Group B)
Number of subjects: 131
Study 35795940 — intervention group
Group type: COMPARATOR
Intervention: Jogging group (Group D)
Number of subjects: 131
Study 34059039 — intervention group
Group type: EXPERIMENTAL
Intervention: Hem-o-lok clips
Number of subjects: 180
Study 34059039 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoloop
Number of subjects: 180
Study 34059039 — intervention group
Group type: EXPERIMENTAL
Intervention: Endostapler
Number of subjects: 180
Study 34059039 — intervention group
Group type: COMPARATOR
Intervention: All study arms
Number of subjects: 180
Study 34979212 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-guided prostate SBRT (40 Gy/5 fractions)
Number of subjects: 20
Study 32002650 — intervention group
Group type: COMPARATOR
Intervention: 4-aminopyridine for the symptomatic treatment of episodic ataxia type 2 and downbeat nystagmus
Number of subjects: 0
Study 35329124 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with one-minute inter-set rest under HH
Number of subjects: 16
Study 35329124 — intervention group
Group type: COMPARATOR
Intervention: Resistance training with two-minute inter-set rest under HH
Number of subjects: 16
Study 35329124 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with one-minute inter-set rest under NH
Number of subjects: 16
Study 35329124 — intervention group
Group type: COMPARATOR
Intervention: Resistance training with two-minute inter-set rest under NH
Number of subjects: 16
Study 35329124 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training under HH
Number of subjects: 16
Study 35329124 — intervention group
Group type: COMPARATOR
Intervention: Resistance training under NH
Number of subjects: 16
Study 33177622 — intervention group
Group type: COMPARATOR
Intervention: BAFF (B cell activating factor) levels in EBV+ patients
Number of subjects: 540
Study 33177622 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro experiments with BAFF on EBV-infected B cells
Number of subjects: 540
Study 33177622 — intervention group
Group type: COMPARATOR
Intervention: B cell expansion in vivo among EBV+ patients
Number of subjects: 540
Study 33177622 — intervention group
Group type: COMPARATOR
Intervention: Inter-correlations of soluble factors in EBV+ patients
Number of subjects: 540
Study 615413969 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline plus thrice-weekly progressive aerobic exercise (S+PAE)
Number of subjects: 121
Study 615413969 — intervention group
Group type: COMPARATOR
Intervention: Sertraline plus thrice-weekly non-progressive exercise (S+NPE)
Number of subjects: 121
Study 34941317 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) for treatment planning (n = 20)
Number of subjects: 40
Study 34941317 — intervention group
Group type: COMPARATOR
Intervention: Clinician-guided treatment planning (n = 20)
Number of subjects: 40
Study 34365067 — intervention group
Group type: EXPERIMENTAL
Intervention: exhalatory-gated RAVANS (e-RAVANS)
Number of subjects: 20
Study 34365067 — intervention group
Group type: COMPARATOR
Intervention: inhalatory-gated RAVANS (i-RAVANS)
Number of subjects: 20
Study 33185375 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided suprascapular nerve block (US-guided SSNB)
Number of subjects: 72
Study 33185375 — intervention group
Group type: COMPARATOR
Intervention: Landmark-guided suprascapular nerve block (landmark-guided SSNB)
Number of subjects: 72
Study 34937846 — intervention group
Group type: EXPERIMENTAL
Intervention: National Career Coach Program
Number of subjects: 0
Study 34937846 — intervention group
Group type: COMPARATOR
Intervention: Local Community Resources
Number of subjects: 0
Study 32853783 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee (3 cups postoperatively at 6, 12, or 18 hours)
Number of subjects: 96
Study 32853783 — intervention group
Group type: COMPARATOR
Intervention: Control (warm water)
Number of subjects: 96
Study 33211928 — intervention group
Group type: COMPARATOR
Intervention: Advice by mail alone
Number of subjects: 9803
Study 33211928 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted exercise in addition to advice by mail
Number of subjects: 9803
Study 33211928 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial fall prevention in addition to advice by mail
Number of subjects: 9803
Study 35835477 — intervention group
Group type: EXPERIMENTAL
Intervention: Kilkari messages (up to 72 messages)
Number of subjects: 5095
Study 35835477 — intervention group
Group type: EXPERIMENTAL
Intervention: Kilkari messages
Number of subjects: 5095
Study 33839105 — intervention group
Group type: COMPARATOR
Intervention: Activity-based training (ABT)
Number of subjects: 16
Study 33839105 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic locomotor training (RLT)
Number of subjects: 16
Study 33839105 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic locomotor training (RLT) and activity‐based training (ABT)
Number of subjects: 16
Study 35692368 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual case-based auscultation course via video chat
Number of subjects: 55
Study 35692368 — intervention group
Group type: COMPARATOR
Intervention: Literature self-study
Number of subjects: 55
Study 33596181 — intervention group
Group type: EXPERIMENTAL
Intervention: TransLife mobile health app
Number of subjects: 16
Study 36117259 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CBT
Number of subjects: 5
Study 36117259 — intervention group
Group type: COMPARATOR
Intervention: Individual CBT
Number of subjects: 5
Study 34871006 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based OurRelationship program
Number of subjects: 742
Study 34871006 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based ePREP program
Number of subjects: 742
Study 34871006 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 742
Study 35220340 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation
Number of subjects: 1021
Study 33060472 — intervention group
Group type: EXPERIMENTAL
Intervention: C-loop haptic toric IOL (AcrySof Toric IOL)
Number of subjects: 62
Study 33060472 — intervention group
Group type: COMPARATOR
Intervention: Plate-haptic toric IOL (AT TORBI 709M IOL)
Number of subjects: 62
Study 36167785 — intervention group
Group type: EXPERIMENTAL
Intervention: Labour inspection visits
Number of subjects: 96
Study 36167785 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidance-through-workshops
Number of subjects: 96
Study 36167785 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 33484027 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine plus conventional treatment (IG)
Number of subjects: 35
Study 33484027 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone (CG)
Number of subjects: 35
Study 36399476 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based bilingual doula support (CBD)
Number of subjects: 164
Study 616824722 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS) lobectomy
Number of subjects: 600
Study 616824722 — intervention group
Group type: COMPARATOR
Intervention: Lobectomy using thoracotomy
Number of subjects: 600
Study 33385766 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 100 mg/day
Number of subjects: 48
Study 33385766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 35064595 — intervention group
Group type: EXPERIMENTAL
Intervention: Response adaptive (RA) design intervention
Number of subjects: 0
Study 35064595 — intervention group
Group type: COMPARATOR
Intervention: Fixed proportion design (control)
Number of subjects: 0
Study 33978693 — intervention group
Group type: EXPERIMENTAL
Intervention: Question prompt list brochure (intervention)
Number of subjects: 213
Study 33978693 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 213
Study 32910709 — intervention group
Group type: COMPARATOR
Intervention: 50 Gy in 25 fractions (n = 937)
Number of subjects: 1882
Study 32910709 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 Gy in 15 fractions (n = 917)
Number of subjects: 1882
Study 35124395 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 1917
Study 35124395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1917
Study 33960924 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.32% Diclofenac Sodium Phonophoresis (DSPH)
Number of subjects: 90
Study 33960924 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.16% Diclofenac Sodium Phonophoresis (DSPH)
Number of subjects: 90
Study 33960924 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic Ultrasound (TUS)
Number of subjects: 90
Study 34068195 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training (additional face-to-face training)
Number of subjects: 65
Study 34068195 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity training (provision with materials and online training)
Number of subjects: 65
Study 32017660 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified cross‐body stretch (MCS)
Number of subjects: 67
Study 32017660 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified sleeper stretch (MSS)
Number of subjects: 67
Study 32017660 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment program consisting of only modalities, range of motion [ROM], and strength training but no PSSEs)
Number of subjects: 67
Study 34674834 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower oxygenation target (8 kPa)
Number of subjects: 2888
Study 34674834 — intervention group
Group type: COMPARATOR
Intervention: Higher oxygenation target (12 kPa)
Number of subjects: 2888
Study 33068819 — intervention group
Group type: COMPARATOR
Intervention: 0.2 % chlorhexidine (CHX) for 5 min (positive control)
Number of subjects: 30
Study 33068819 — intervention group
Group type: EXPERIMENTAL
Intervention: Phycocyanin alone with ×2 MIC concentration for 5 min
Number of subjects: 30
Study 33068819 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser alone (635 nm wavelength, 220 mW power)
Number of subjects: 30
Study 33068819 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with diode laser and phycocyanin
Number of subjects: 30
Study 33068819 — intervention group
Group type: COMPARATOR
Intervention: Negative control with no treatment
Number of subjects: 30
Study 33022318 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivationally-tailored, computer-assisted counseling intervention
Number of subjects: 360
Study 33022318 — intervention group
Group type: COMPARATOR
Intervention: Control condition (toll-free quitline)
Number of subjects: 360
Study 33022318 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 360